Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Smith & Nephew Snats ADR
(NY:
SNN
)
25.23
+0.19 (+0.76%)
Streaming Delayed Price
Updated: 10:13 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Smith & Nephew Snats ADR
< Previous
1
2
Next >
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
October 31, 2024
Via
Benzinga
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 05, 2024
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family
Via
Benzinga
Macy's, Koss And Other Big Stocks Moving Higher On Friday
July 05, 2024
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Will Investors Notice Exciting Sign On Smith & Nephew's Chart?
January 30, 2023
Via
Benzinga
Smith & Nephew's Implant Shows 86% Reduction In Re-Tear Rates After Shoulder Surgery
September 14, 2022
Via
Benzinga
Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge
July 05, 2024
Smith & Nephew shares rise as Cevian Capital acquires a 5% stake, aiming to improve operational performance. The medical tech firm faces challenges with declining market cap and mixed revenue growth.
Via
Benzinga
4 Stocks to Watch in the Booming Regenerative Medicine Market
May 20, 2024
4 Stocks to Watch in the Booming Regenerative Medicine Market
Via
News Direct
Current Analysis: Smith & Nephew
May 17, 2024
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from...
Via
Talk Markets
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
March 13, 2024
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.
Via
InvestorPlace
British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism
March 12, 2024
Smith & Nephew shakes up executive pay structure, aligning with US standards to curb turnover. Chairman Rupert Soames addresses global talent recruitment challenges and the shift's significance in the...
Via
Benzinga
Smith & Nephew Shares Fall On Lower Margins As Cost Headwinds Hit Q2 Profit
July 28, 2022
Via
Benzinga
Smith & Nephew Posts Q1 Sales Growth As Elective Procedures Rebound
April 28, 2022
Via
Benzinga
3 Millionaire-Maker Robotics Stocks to Buy in February 2024
February 21, 2024
Jump into the future with top robotics stocks poised for explosive growth. Discover the potential for massive returns.
Via
InvestorPlace
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
October 04, 2023
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell...
Via
Benzinga
Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength
August 03, 2023
Smith & Nephew PLC (NYSE: SNN) reported improved revenue, profit, and margin in the
Via
Benzinga
AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday
July 03, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares...
Via
Benzinga
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck
June 29, 2023
Via
Benzinga
Boeing, CyberArk Lead 5 Stocks Near Buy Points
June 17, 2023
The market rally is going strong, but watch out for a potential pullback.
Via
Investor's Business Daily
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout
June 14, 2023
UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring.
Via
Investor's Business Daily
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter
April 27, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Burberry Finance Chief Joins GSK As First Woman CFO
September 26, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 02, 2022
Tuesday's session saw 63 companies set new 52-week lows.
Via
Benzinga
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
July 28, 2022
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 01, 2022
On Monday, 92 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 28, 2022
Via
Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
July 29, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
Gainers
Via
Benzinga
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
July 28, 2022
Gainers JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.